Skip to content
Life sciences consumables, equipment and services, delivered across Saudi Arabia.
Anti-Vitronectin  Antibody
  • Anti-Vitronectin  Antibody
Antibodies.com

Anti-Vitronectin Antibody

Price on request

SKUPriceQuantity
A32387-50

Price on request

Description

This description has not been verified against the manufacturer's datasheet. Check the datasheet before you order, or ask us to confirm a specification. Ask us to confirm

Manufactured by Antibodies.com, this recombinant rabbit monoclonal reagent is raised against Vitronectin and is supplied as50 µl of an unconjugated, affinity-validated preparation. The antibody is formulated in 1× TBS (pH7.4) containing 1% BSA and 40% glycerol, with 0.05% sodium azide added as a preservative, and should be stored refrigerated (typically at2–8 °C) to preserve activity across multiple freeze-thaw cycles. It is a rabbit IgG monoclonal host antibody produced recombinantly, providing the batch-to-batch consistency expected of a clonally defined reagent and is certified for research use only. The target, Vitronectin, is detected in samples from human, mouse and rat, making this reagent suitable for cross-species studies of cell adhesion, complement regulation and pericyte biology. Verified applications include Western Blot (WB), Immunocytochemistry/Immunofluorescence (ICC/IF) and Immunohistochemistry (IHC), so the same lot can be used to confirm a band of the expected molecular weight by WB, localise Vitronectin in cultured cells by ICC/IF, and visualise its distribution in fixed tissue sections by IHC. As supplied, the product is unconjugated, allowing end users to pair it with their own secondary antibody or label of choice (HRP, biotin, fluorophores, or gold) according to the detection platform in use. Combined with the recombinant production format and the broad Human/Mouse/Rat reactivity, this Antibodies.com reagent offers a flexible, lot-controlled primary antibody option for laboratories studying extracellular matrix components, integrin signalling, or vitronectin–dependent processes in normal and disease models.